AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...

The trial will assess ENHERTU (at a dose of 5.4 mg/kg) in combination with either rilvegostomig or pembrolizumab, compared to the current standard of care, platinum-based chemotherapy (carboplatin ...

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

Zongertinib met its primary objective, with an objective response rate of 66.7% and a low rate (3%) of treatment discontinuations due to toxicity in the NSCLC group given the dose selected for the ...

AstraZeneca and Daiichi Sankyo are preparing regulatory filings that could make their HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the ...

Mounjaro’s typical starting dosage is 2.5 milligrams (mg) once per week for 4 weeks, after which your doctor may increase the dose to 5 mg per week if needed to manage blood sugar levels.

Typically, your doctor will start you on a low dosage and adjust it over time to reach the dosage that’s right for you. They’ll ultimately prescribe the smallest dosage that provides the ...

Earnings Call Insights Daiichi Sankyo sees ENHERTU sales reaching ¥539.9B in FY2024 amid oncology momentum SA Insights Fri, Jan. 31 Daiichi Sankyo Company, Limited 2024 Q3 - Results - Earnings ...